Crowdonomics
SMART RX SYSTEMS INC

Reg A+ · Equity · Jun 2025

OpenReg A+Equity
via ANDES CAPITAL GROUP, LLC · last checked Aug 16, 2026
Raised
$0 / $50M max
0% of ceiling
Investors
—
—
Momentum
$0/day
—

Financials disclosed in this offering

FY2023 · hover for source
$7K
−$2.7M
FY2023
RevenueNet income
Metric
FY2023 audited
Income statement
Revenue
$6,586
Cost of goods sold
$161,267
Gross margin
-2349%
Net income
-$2,743,749
Balance sheet
Cash
$555
Accounts receivable
$0
Total assets
$6,249,297
Long-term debt
$10,728,592
Total liabilities
$14,822,808
Other
Headcount
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. May 2, 2025
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗
  2. Apr 3, 2025
    • Price $100000 → $10
    Form 1-A/A on EDGAR ↗
  3. Nov 26, 2024
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗
  4. Oct 24, 2024
    • Price $10 → $100000
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$68.9M
Price / share$10.00
Shares offered5,000,000

Estimated, not stated: $10.00 × 6,891,307 as-converted securities outstanding.

Offering details

Target—
Max$50,000,000
Min investment—
OpenedJun 4, 2025
Deadline—
Days active492

Links & provenance

Source: SEC EDGAR
0001539497-24-000848
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.